Skip to main content

Table 2 Microorganisms associated with ventilator associated tracheobronchitis

From: Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia

 

Subsequent VAP

 

Yes n = 17

No n = 105

Microorganisms, n

20

118

Polymicrobial VAT

3 (17)

13 (7)

MDR bacteria

8 (47)

37 (35)

Gram-negative

17 (100)

91 (86)

  Pseudomonas aeruginosa

4 (23)a

38 (36)a

  Enterobacter species

2 (11)b

10 (9)b

  Escherichia coli

1 (5)

5 (4)c

  Proteus mirabilis

0 (0)

3 (2)

  Citrobacter freundii

1 (5)

3 (2)

  Acinetobacter baumannii

4 (23)

10 (9)

  Morganella morgani

0 (0)

5 (4)

  Hemophilus influenzae

1 (5)

2 (1)

  Stenotrophomonas maltophilia

0 (0)

4 (3)

  Klebsiella oxytoca

4 (23)d

9 (8)d

  Serratia species

0 (0)

2 (1)

Gram-positive

3 (17)

27 (25)

  Methicillin-resistant S. aureus

1 (5)

11 (10)

  Methicillin-sensitive S. aureus

1 (5)

12 (11)

  Streptococcus pneumoniae

1 (5)

4 (3)

  1. Data are n (%). aIncluding one, and four MDR species, respectively; bincluding one, and three MDR species, respectively; cincluding one MDR; dincluding one, and three MDR species; respectively. P >0.1 for all comparisons between the two groups. VAP, ventilator-associated pneumonia; VAT, ventilator-associated tracheobronchitis; MDR, multidrug-resistant bacteria.